Nektar TherapeuticsNKTR stock score: 27/100
$32.54 · -5.46% · Scored Nov 19, 2026
- Technical
- 25
- Fundamental
- 28
- News
- 41
The reading
Nektar Therapeutics (NKTR) scores 27 out of 100, which reads bearish, higher than 2% of Healthcare stocks and 2% of the 4,118 US stocks we score.
The composite weights fundamentals 80% and technicals 20%: fundamentals read 28, technicals 25.
Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 14 and contrarian oscillators 69 — a split worth reading before trusting the technical total.
News sentiment is neutral at 41; it is shown, not counted in the composite.
Since Aug 22, 2026 the composite has ranged from 25 to 50, and it is down 14 points over the period.
About Nektar Therapeutics
Nektar Therapeutics (NKTR) is a clinical-stage biotechnology company focused on treatments that work by modulating the immune system. Its lead product candidate is rezpegaldesleukin, often called rezpeg, a drug designed to stimulate regulatory T cells, which help calm overactive immune responses. Rezpeg is in late-stage development for moderate-to-severe atopic dermatitis, and the company plans a late-stage study in severe alopecia areata after mid-stage trials in both conditions. The U.S. Food and Drug Administration has granted Fast Track designation for rezpeg in both indications. Nektar also has earlier-stage immunology programs drawn from its research platform. The company built much of its history on polymer chemistry technology used in medicines sold by larger drugmakers, but it has since narrowed its focus to its own immunology pipeline. Nektar has little product revenue and funds its research mainly with its cash reserves and sales of stock.
Nektar competes with makers of approved and developing treatments for atopic dermatitis and alopecia areata, including Sanofi and Regeneron, Eli Lilly, AbbVie and Pfizer. Its edge rests on rezpeg’s different mechanism, which aims to restore immune balance rather than block a single inflammatory signal, and the potential for less frequent dosing. Investors who follow NKTR stock tend to watch enrollment and results from the late-stage atopic dermatitis program. Durability data and plans for alopecia areata are closely followed. Cash runway, potential partnerships and share dilution are other factors.
What’s driving the score
The strongest and weakest of the scorers that count toward NKTR’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
28Pulling it up
- Quick Ratio100
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
Current assets divided by current liabilities: the ability to pay short-term bills.
Holding it back
Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.
Absolute profitability: whether the company is profitable, its net margin against the sector range, and how consistently it has been profitable over three years.
5-year earnings growth evaluates long-term profit trajectory and consistency.
37 weighted scorers; 2 had no data today and are left out rather than counted as zero.
Technical · daily
20Pulling it up
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
- RSI (14)88
Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.
Williams %R (28-period) places the close within the last 28 periods' high-low range.
Holding it back
Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.
Where the price sits between its 52-week low and high.
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 41
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 28 | 1 |
| Daily | 20 | 3 |
| Weekly | 24 | 2 |
| Monthly | 30 | 2 |
| Quarterly | 27 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Nov 19, 2026 | 27 |
| Nov 18, 2026 | 27 |
| Nov 17, 2026 | 27 |
| Nov 16, 2026 | 27 |
| Nov 15, 2026 | 27 |
| Nov 14, 2026 | 27 |
| Nov 13, 2026 | 27 |
| Nov 12, 2026 | 25 |
| Nov 11, 2026 | 29 |
| Nov 10, 2026 | 29 |
| Nov 9, 2026 | 29 |
| Nov 8, 2026 | 28 |
| Nov 7, 2026 | 28 |
| Nov 6, 2026 | 27 |
| Nov 5, 2026 | 27 |
| Nov 4, 2026 | 30 |
| Nov 3, 2026 | 28 |
| Nov 2, 2026 | 27 |
| Nov 1, 2026 | 30 |
| Oct 31, 2026 | 28 |
| Oct 30, 2026 | 29 |
| Oct 29, 2026 | 30 |
| Oct 28, 2026 | 29 |
| Oct 27, 2026 | 29 |
| Oct 26, 2026 | 28 |
| Oct 25, 2026 | 28 |
| Oct 24, 2026 | 27 |
| Oct 23, 2026 | 27 |
| Oct 22, 2026 | 29 |
| Oct 21, 2026 | 29 |
| Oct 20, 2026 | 29 |
| Oct 19, 2026 | 28 |
| Oct 18, 2026 | 27 |
| Oct 17, 2026 | 26 |
| Oct 16, 2026 | 26 |
| Oct 15, 2026 | 27 |
| Oct 14, 2026 | 26 |
| Oct 13, 2026 | 27 |
| Oct 12, 2026 | 28 |
| Oct 11, 2026 | 29 |
| Oct 10, 2026 | 29 |
| Oct 9, 2026 | 29 |
| Oct 8, 2026 | 28 |
| Oct 7, 2026 | 28 |
| Oct 6, 2026 | 27 |
| Oct 5, 2026 | 26 |
| Oct 4, 2026 | 28 |
| Oct 3, 2026 | 28 |
| Oct 2, 2026 | 27 |
| Oct 1, 2026 | 28 |
| Sep 30, 2026 | 32 |
| Sep 29, 2026 | 31 |
| Sep 28, 2026 | 31 |
| Sep 27, 2026 | 29 |
| Sep 26, 2026 | 29 |
| Sep 25, 2026 | 30 |
| Sep 24, 2026 | 31 |
| Sep 23, 2026 | 31 |
| Sep 22, 2026 | 31 |
| Sep 21, 2026 | 34 |
| Sep 20, 2026 | 36 |
| Sep 19, 2026 | 36 |
| Sep 18, 2026 | 35 |
| Sep 17, 2026 | 35 |
| Sep 16, 2026 | 34 |
| Sep 15, 2026 | 34 |
| Sep 14, 2026 | 35 |
| Sep 13, 2026 | 36 |
| Sep 12, 2026 | 36 |
| Sep 11, 2026 | 36 |
| Sep 10, 2026 | 36 |
| Sep 9, 2026 | 38 |
| Sep 8, 2026 | 42 |
| Sep 7, 2026 | 41 |
| Sep 6, 2026 | 41 |
| Sep 5, 2026 | 41 |
| Sep 4, 2026 | 40 |
| Sep 3, 2026 | 50 |
| Sep 2, 2026 | 40 |
| Sep 1, 2026 | 39 |
| Aug 31, 2026 | 37 |
| Aug 30, 2026 | 39 |
| Aug 29, 2026 | 39 |
| Aug 28, 2026 | 39 |
| Aug 27, 2026 | 41 |
| Aug 26, 2026 | 41 |
| Aug 25, 2026 | 41 |
| Aug 24, 2026 | 39 |
| Aug 23, 2026 | 41 |
| Aug 22, 2026 | 41 |
Key facts
- Market cap
- $1.1B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 1.42
- Risk grade (1–10)
- 4
- Next earnings
- Nov 12, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| AAPG Ascentage Pharma Group Internat | $1.2B | 45 |
| SVRA Savara | $1.1B | 38 |
| VOR Vor Biopharma | $1.1B | 43 |
| INBX Inhibrx Biosciences | $1.1B | 38 |
| ANRO Alto Neuroscience | $1.1B | 36 |
| DRTS Alpha Tau Medical | $1.0B | 30 |
Questions
What is NKTR's stock rating today?
NKTR scores 27/100 (Bearish) as of Nov 19, 2026: technical 25, fundamental 28, and news sentiment 41, which is shown but not counted. Scores are recomputed every night.
What does Nektar Therapeutics do?
Nektar Therapeutics (NKTR) is a clinical-stage biotechnology company focused on treatments that work by modulating the immune system. Its lead product candidate is rezpegaldesleukin, often called rezpeg, a drug designed to stimulate regulatory T cells, which help calm overactive immune responses.
Is NKTR stock a buy?
The score is not a buy or sell recommendation. A 27 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the NKTR score calculated?
99 weighted scorers feed it today: 37 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.
Embed this score
A badge for a blog post, newsletter or README. It updates every night and links back here. More badges
HTML
<a href="https://stocksscores.com/stocks/nktr/"><img src="https://stocksscores.com/stocks/nktr/badge.svg" alt="NKTR stock score" height="20"></a>
Markdown
[](https://stocksscores.com/stocks/nktr/)